Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 676,067 |
|
|||||
| News | - | ||||||
| Day High | 0.7996 | Low High |
|||||
| Day Low | 0.731 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0358 | 4.88% | 0.77 | 19:59:31 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.74 | 0.731 | 0.7996 | 0.7673 | 0.7342 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,226 | 676,067 | $ 0.7716496 | $ 521,687 | - | 0.60 - 1.6189 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:30 | 77 | $ 0.77 | USD |
Citius Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 120.91M | 159.09M | - | 0 | -33.69M | -0.21 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7564 | 1.04 | 0.70 | 0.786742 | 2,099,953 | 0.0136 | 1.80% |
| 1 Month | 0.82 | 1.07 | 0.70 | 0.8609756 | 1,266,534 | -0.05 | -6.10% |
| 3 Months | 0.69 | 1.07 | 0.60 | 0.7916367 | 839,555 | 0.08 | 11.59% |
| 6 Months | 0.67 | 1.07 | 0.60 | 0.7770438 | 719,924 | 0.10 | 14.93% |
| 1 Year | 1.58 | 1.6189 | 0.60 | 1.01 | 1,059,227 | -0.81 | -51.27% |
| 3 Years | 1.79 | 4.56 | 0.60 | 1.97 | 2,007,420 | -1.02 | -56.98% |
| 5 Years | 1.07 | 4.56 | 0.40 | 1.82 | 2,249,717 | -0.30 | -28.04% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome. |
